Thrombolytic Drug Market, Global Outlook and Forecast 2023-2028

Thrombolytic drugs, which dissolve solid blood clots, are commonly used to treat clot complications such as acute myocardial infarction, pulmonary embolism, deep venous thrombosis, blocked catheters, and acute ischemic stroke.Urokinase, streptokinase and tissue plasminogen activator (tPA) are the basic thrombolytic agents available on the market for thrombolytic therapy.Divided into fibrin - specific drugs and non - fibrin - specific drugs.The fibrin-specific drug segment is further divided into tissue plasminogen activator, retiplase, tenaiplase, etc.Nonfibrin-specific drugs are subdivided into urokinase, streptokinase, and plasminogen activated complexes.
This report contains market size and forecasts of Thrombolytic Drug in Global, including the following market information:
Global Thrombolytic Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Thrombolytic Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Fibrin Specific Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Thrombolytic Drug include Roche, Sedico Pharmaceuticals, Eumedica, Genentech, Microbix, Medac, Mochida Pharmaceutical, Taj Pharmaceuticals and Wulfing Pharma GmbH. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Thrombolytic Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Thrombolytic Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Thrombolytic Drug Market Segment Percentages, by Type, 2021 (%)
Fibrin Specific Drugs
Nonfibrin-specific Drugs
Global Thrombolytic Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Thrombolytic Drug Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacy
Retail Pharmacies
Electronic Pharmacy
Global Thrombolytic Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Thrombolytic Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Thrombolytic Drug revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Thrombolytic Drug revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Sedico Pharmaceuticals
Eumedica
Genentech
Microbix
Medac
Mochida Pharmaceutical
Taj Pharmaceuticals
Wulfing Pharma GmbH